Cardiomatics
AI cardiac diagnostics · Arrhythmia detection
Overview
Cloud AI that reads ECG signals to detect arrhythmias; deployed across European clinics — a commercial Polish health-AI exporter.
What they do
Cardiomatics is a Polish health-AI company offering cloud-based, medical-grade software that automatically analyzes ambulatory (Holter) ECG recordings. Its clinically validated machine-learning algorithms detect arrhythmias and other cardiac events, reducing the manual workload for cardiologists and technicians. The platform is CE-marked and certified under the EU Medical Device Regulation (MDR), and its models have reportedly processed over 8 million hours of ECG data.
Lead program & status
Cardiomatics is a commercial-stage product, not a clinical-trial pipeline. Its flagship cloud ECG-analysis service is deployed across clinics in multiple European countries. As of 2024-2025, the company released Cardiomatics v5, reportedly the first AI ECG-interpretation software certified under MDR, adding features such as AV-block detection and fast-track analysis. It also partnered with Biotronik to support remote cardiac monitoring in Germany and is collaborating with the Medical University of Warsaw on "Cardiomatics Junior" for pediatric ECG assessment, backed by Poland's NCBR.
Why it matters
Cardiomatics is a rare example of a profitable, exporting Polish medical-AI company scaling a regulated product across European healthcare systems.
FAQ
- What does Cardiomatics do?
- It provides cloud-based, MDR-certified AI software that automatically analyzes Holter/ambulatory ECG recordings to detect arrhythmias and other cardiac events.
- Is Cardiomatics a regulated medical device?
- Yes. The software is CE-marked and certified under the EU Medical Device Regulation (MDR); its v5 release was promoted as the first AI ECG-interpretation tool certified under MDR.
- Where is Cardiomatics used?
- It is deployed commercially across clinics in multiple European countries, with partnerships such as one with Biotronik in Germany.
Technology
Cardiomatics works in AI-Driven Drug Discovery — Compressing years of trial-and-error chemistry into months of computation.
Read the AI-Driven Drug Discovery brief →Related companies
Company website / source ↗ Open the interactive map →
Get ahead of the next biotech boom.
New companies, stage changes, deal alerts and fresh tech briefs — one sharp email when the map moves.